Effect of fibroblast-derived interferon administration on immune responsiveness in a patient with nasopharyngeal carcinoma.
D002277:Carcinoma / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy; D007370:Interferon Type I / Q000494:pharmacology / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D009303:Nasopharyngeal Neoplasms / Q000276:immunology / Q000628:therapy*
D007370:Interferon Type I